{"acquired gene mutation": 81.21, "acute lymphocytic leukaemia": 56.66, "acute lymphocytic leukaemia recurrent": 149.26, "arthritis": 2.25, "blast crisis in myelogenous leukaemia": 260.68, "chronic myeloid leukaemia": 148.28, "chronic myeloid leukaemia recurrent": 523.42, "cytogenetic analysis abnormal": 764.35, "cytomegalovirus colitis": 93.39, "cytopenia": 13.34, "drug hypersensitivity": 2.64, "drug ineffective": 2.46, "drug intolerance": 43.71, "drug resistance": 74.7, "febrile neutropenia": 2.3, "intentional product use issue": 4.38, "leukocytosis": 8.49, "lipase increased": 16.88, "malignant neoplasm progression": 6.06, "muscle spasms": 2.33, "myelosuppression": 2.83, "myocardial ischaemia": 17.89, "pancreatitis": 4.06, "pancytopenia": 5.74, "philadelphia chromosome positive": 354.17, "platelet count decreased": 3.38, "pleural effusion": 25.74, "pulmonary hypertension": 19.16, "rectal haemorrhage": 3.27, "supraventricular tachycardia": 20.97, "therapeutic response decreased": 17.09, "therapy non-responder": 10.21, "thrombocytopenia": 3.78, "toxicity to various agents": 7.08, "treatment failure": 19.1, "white blood cell count increased": 4.93}